In Vitro Antibiotic Susceptibility of Initial Pseudomonas aeruginosa Isolates From United States Cystic Fibrosis Patients

被引：5

作者：

VanDevanter, Donald R. ^{[1
]}

Van Dalfsen, Jill M. ^{[2
]}

Burns, Jane L. ^{[3
,4
]}

Mayer-Hamblett, Nicole ^{[4
,5
]}

机构：

[1] Case Western Reserve Univ, Sch Med, Pediat, Cleveland, OH 44106 USA

[2] Univ Washington, Seattle Childrens Res Inst, Seattle, WA 98195 USA

[3] Univ Washington, Seattle Childrens Hosp, Infect Dis, Seattle, WA 98195 USA

[4] Univ Washington, Pediat, Seattle, WA 98195 USA

[5] Seattle Childrens Res Inst, Biomed Stat, Seattle, WA 98101 USA

来源：

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY | 2015年 / 4卷 / 02期

关键词：

cystic fibrosis; initial P aeruginosa; susceptibility;

D O I：

10.1093/jpids/pit052

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Chronic antibiotic suppression of cystic fibrosis (CF) infections has increased in the United States, as has isolation of Pseudomonas aeruginosa with reduced antibiotic susceptibility. However, analysis of the susceptibilities of 193 initial P aeruginosa clinical isolates suggests that antibiotic susceptibilities are comparable with wild-type strains despite expanded antipseudomonal treatment in the CF community.

引用

页码：151 / 154

页数：4

共 50 条

[41] In vitro pharmacodynamic properties of colistin and colistin methanesulfonate against Pseudomonas aeruginosa isolates from patients with cystic fibrosis
Li, J
Turnidge, J
Milne, R
Nation, RL
Coulthard, K
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (03) : 781 - 785
[42] In vitro activity of meropenem, imipenem, cefepime and ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients
Christenson, JC
Korgenski, EK
Daly, JA
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 45 (06) : 899 - 901
[43] Hypertonic saline inhibits in vitro growth of pseudomonas aeruginosa (pa) isolates from patients with cystic fibrosis (cf)
Casaulta, C.
Troller, R.
Schoeni, M. H.
Aebi, C.
SWISS MEDICAL WEEKLY, 2008, 138 : 32S - 32S
[44] In vitro activity of doripenem against Pseudomonas aeruginosa and Burkholderia cepacia isolates from both cystic fibrosis and non-cystic fibrosis patients
Traczewski, MM
Brown, SD
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (02) : 819 - 821
[45] Antibiotic susceptibilities of Pseudomonas aeruginosa isolates derived from patients with cystic fibrosis under aerobic, anaerobic, and biofilm conditions
Hill, D
Rose, B
Pajkos, A
Robinson, M
Bye, P
Bell, S
Elkins, M
Thompson, B
MacLeod, C
Aaron, SD
Harbour, C
JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (10) : 5085 - 5090
[46] COST OF PSEUDOMONAS AERUGINOSA IN CYSTIC FIBROSIS PATIENTS IN THE UNITED KINGDOM
Smalarz, A.
Harrow, B.
Pashos, C. L.
Schoeman, O.
VALUE IN HEALTH, 2009, 12 (03) : A192 - A192
[47] INTERIM DATA (YEAR 4) FROM A PROSPECTIVE 5-YEAR REGISTRY STUDY TO MONITOR AZTREONAM SUSCEPTIBILITY OF PSEUDOMONAS AERUGINOSA ISOLATES FROM CYSTIC FIBROSIS PATIENTS IN THE UNITED STATES
Keating, C.
Zuckerman, J. B.
Singh, P.
McKevitt, M.
Gurtovaya, O.
Bresnik, M.
Marshall, B.
Saiman, L.
PEDIATRIC PULMONOLOGY, 2017, 52 : S370 - S370
[48] CHANGING SUSCEPTIBILITY OF PSEUDOMONAS-AERUGINOSA ISOLATES FROM CYSTIC-FIBROSIS PATIENTS WITH THE CLINICAL USE OF NEWER ANTIBIOTICS
BOSSO, JA
ALLEN, JE
MATSEN, JM
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (04) : 526 - 528
[49] Cumulative Antimicrobial Susceptibility Data of Pseudomonas Aeruginosa Isolates from Cystic Fibrosis Patients: 4-Year Experience
Fidan, Ebru
Alci, Gamze
Koldas, Seda Sevilay
Gokdemir, Yasemin
Karadag, Bulent
Eralp, Ela Erdem
Yagci, Aysegul Karahasan
JOURNAL OF PEDIATRIC INFECTIOUS DISEASES, 2021, 16 (05) : 242 - 246
[50] Population Structure and Antimicrobial Susceptibility of Both Nonpersistent and Persistent Pseudomonas aeruginosa Isolates Recovered from Cystic Fibrosis Patients
Fernandez-Olmos, Ana
Garcia-Castillo, Mara
Maria Alba, Jose
Isabel Morosini, Mara
Lamas, Adelaida
Romero, Beatriz
Carlos Galan, Juan
del Campo, Rosa
Canton, Rafael
JOURNAL OF CLINICAL MICROBIOLOGY, 2013, 51 (08) : 2761 - 2765

← 1 2 3 4 5 →